fda warning letter compounding semaglutide news New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Out of Shortage, Into Controversy:

Thiazolidinediones (TZD) drugs Systematic reviews and meta-analyses have demonstrated that TZD drugs are associated with a reduction in lung cancer risk in patients with type 2 diabetes of approximately 20% [98], and has a preventive effect on prostate cancer [102]

Effects of semaglutide and empagliflozin on inflammatory markers in patients with type 2 diabetes

PT-141 was developed as the safer, more targeted alternative

Glutathione levels in the body can be depleted by air pollution, which increases the need for antioxidants to neutralize inhaled toxins

But we can treat it, and everyone I start on these medications can tolerate it because we have a protocol that helps relieve and prevent these side effects